Battling the intense heat and striving for high yields—Shanghai Luxiangyi has once again delivered another batch of ultra-large-capacity refrigerated centrifuges!

Lu Xiangyi has successfully delivered another batch of DL-8M ultra-large-capacity refrigerated centrifuges.

　　Since the summer solstice, the hot weather has officially begun. To live up to our customers’ trust and support, Shanghai Luxiangyi Centrifuge Instrument Co., Ltd. (hereinafter referred to as “Shanghai Luxiangyi”) has been battling the high temperatures and striving for high productivity. On June 28, the company successfully delivered another batch of DL-8M ultra-large-capacity refrigerated centrifuges to a biopharmaceutical enterprise for use.

　　Ten ultra-large-capacity refrigerated centrifuges from Shanghai Luxiangyi have been loaded onto the truck.

　　It is reported that this time... Centrifuge The shipment quantity is 10 units. Currently, the pharmaceutical company has 20 DL-8M high-capacity refrigerated centrifuges manufactured by Shanghai Luxiangyi operating in its production workshop. These devices continuously separate and purify the substances required by the manufacturing enterprise. Moreover, after on-site maintenance services provided by Shanghai Luxiangyi’s centrifuge after-sales team, testing has shown that the machines are running stably and producing excellent data.

　　A workshop of a biopharmaceutical company

　　According to available information, Shanghai Luxiangyi is a Chinese centrifuge manufacturer that has obtained U.S. FDA certification. The company has been in operation for over four decades and is headquartered in the Zhoupu Industrial Park, Pudong New Area, Shanghai. Its campus covers an area of 7,000 square meters, with standard factory buildings totaling 9,000 square meters. Currently, the company has established stable technical and supply partnerships for centrifuge products with numerous well-known universities, hospitals, petrochemical, pharmaceutical, food, high-tech enterprises, and research institutions across China.

　　In recent years, as the aging population has continued to intensify, demand for pharmaceutical products has kept expanding. Coupled with the growing R&D investments by biopharmaceutical companies, the increasing attention paid by the Chinese government to the biopharmaceutical industry, the continuous introduction of supportive policies, and sustained investor interest, China’s biopharmaceutical industry has been steadily expanding in scale. The pandemic since 2020 has further presented significant development opportunities in certain sub-sectors of the biopharmaceutical industry, driving an even greater expansion of the industry’s overall size. According to data projections, China’s biopharmaceutical industry will grow from 3 trillion yuan in 2018 to 4 trillion yuan in 2022. Industry insiders anticipate that the sector will also experience a new wave of investment growth over the coming decades. Against this backdrop, related biopharmaceutical production equipment industries—such as centrifuge manufacturers—will face both more opportunities and greater challenges.

　　It is understood that, compared with traditional chemical pharmaceutical manufacturing processes, biopharmaceutical production leverages modern biotechnology methods such as genetic engineering, genetic modification, cell engineering, and enzyme engineering. The resulting production processes are highly complex, involving key technical stages including the construction of genetically engineered cells or strains, industrial-scale scaling up of high-density, high-expression fermentation processes, and the separation and purification of recombinant proteins. Consequently, this industry places high demands on the expertise of equipment, instruments, and technical personnel, and the production process requires close monitoring.

　　As a manufacturer and supplier of centrifuge equipment, including laboratory centrifuges, for domestic pharmaceutical companies, Shanghai Luxiangyi, guided by the nation’s policies aimed at benefiting the people, continues to contribute its own strength to China’s biopharmaceutical production through strong partnerships with major pharmaceutical enterprises. Recently, its independently developed and produced DL-8M ultra-large-capacity refrigerated centrifuge has also attracted considerable attention within the industry.

　　Lu Xiangyi DL-8M Ultra-Large-Capacity Refrigerated Centrifuge

　　According to the introduction, this machine can reach a rotational speed of up to 8,000 r/min and has a capacity of up to 2,400 ml × 6, with a single-sample processing volume of up to 14,400 ml. In terms of safety, it is equipped with an electronic door lock and features multiple protective functions, including automatic door-locking, overspeed protection, overtemperature protection, and imbalance detection. Additionally, it boasts an automatic alarm system for detecting faults, ensuring both safety and reliability.

　　In addition to the features mentioned above, intelligence is another key highlight of the DL-8M ultra-large-capacity refrigerated centrifuge. Currently, manufacturing is in the foundational stage of digital transformation. As 5G accelerates its rollout, artificial intelligence will become one of the major trends driving the development of the manufacturing industry. The DL-8M large-capacity low-speed refrigerated centrifuge precisely adopts a touch panel and offers programmable operation; its host operating parameters can be set according to specific needs and are automatically saved. Under conditions that ensure safety, this not only reduces labor costs but also boosts production efficiency.

　　As the saying goes, “A nation takes its people as its foundation; the people regard food as their heaven; and food safety comes first.” Food and drug safety is closely linked to the happiness of countless families. Shanghai Luxiangyi has always been committed to safeguarding the safe production of pharmaceuticals in China. Regarding this successful delivery, Shanghai Luxiangyi staff expressed their confidence that Luxiangyi’s DL-8M ultra-large-capacity refrigerated centrifuge will surely provide customers with more efficient and safer support for their production!

　　Attachment: The 9 Key Features of the DL-8M Ultra-Large-Capacity Refrigerated Centrifuge:

　　1. The rotational speed can reach up to 8,000 rpm, the capacity can reach up to 2,400 ml × 6, and the single-sample processing volume can reach up to 14,400 ml.

　　2. Microcomputer-controlled, driven by a high-torque AC variable-frequency motor, ensuring stable operation, low noise, and high speed accuracy.

　　3. It features an imported high-performance compressor unit and a fluorine-free refrigerant, R404a, which meets environmental protection standards and delivers excellent cooling performance.

　　4. Touch panel, programmable operation; host operating parameters can be set according to requirements and automatically stored.

　　5. A large-screen LCD display and digital display are available for selection, featuring a user-friendly interface that is simple and convenient to operate.

　　6. Real-time conversion and setting between RPM and RCF for convenient and quick operation.

　　7. Equipped with an electronic door lock, it features multiple protective functions including self-locking door cover, overspeed protection, overtemperature protection, and imbalance detection; it also has an automatic fault alarm function, ensuring safety and reliability.

　　8. Features 10 programmed ramp-up/ramp-down curves, with adjustable ramp-up and ramp-down times as needed.

　　9. Uses an integral sealing ring made of food-grade silicone rubber, compliant with GMP certification. The centrifuge has obtained U.S. FDA certification.